Ganciclovir for Cytomegalovirus: a Call for Indefinite Prophylaxis in Lung Transplantation
- 31 August 2008
- journal article
- research article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 27 (8), 875-881
- https://doi.org/10.1016/j.healun.2008.05.009
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Combined CMV Prophylaxis Improves Outcome and Reduces the Risk for Bronchiolitis Obliterans Syndrome (BOS) after Lung TransplantationTransplantation, 2006
- Association of Minimal Rejection in Lung Transplant Recipients with Obliterative BronchiolitisAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Following Universal Prophylaxis with Intravenous Ganciclovir and Cytomegalovirus Immune Globulin, Valganciclovir is Safe and Effective for Prevention of CMV Infection Following Lung TransplantationAmerican Journal of Transplantation, 2004
- Cytomegalovirus Prophylaxis and Graft Outcome in Solid Organ Transplantation: A Collaborative Transplant Study ReportAmerican Journal of Transplantation, 2004
- Combination Prophylaxis with Ganciclovir and Cytomegalovirus (CMV) Immune Globulin After Lung Transplantation: Effective CMV Prevention Following Daclizumab InductionAmerican Journal of Transplantation, 2003
- Success of lung transplantation without surveillance bronchoscopyThe Journal of Heart and Lung Transplantation, 2002
- Use of cytomegalovirus immune globulin and ganciclovir for the prevention of cytomegalovirus disease in lung transplantationTransplant Infectious Disease, 2001
- Infection in Organ-Transplant RecipientsNew England Journal of Medicine, 1998
- A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.American Journal of Respiratory and Critical Care Medicine, 1994
- Sequelae of Cytomegalovirus Pulmonary Infections in Lung Allograft RecipientsAmerican Review of Respiratory Disease, 1992